Mirjam C.A. de Weijert

Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250

Karin Grabmaier, Joost L. M. Vissers, Mirjam C.A. de Weijert et al. · International Journal of Cancer · 2000 · 179 citations

Medicine, Molecular Biology, Oncology +17

Tyrosine Kinase Inhibitor Sorafenib Decreases ¹¹¹In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma

Alexander B. Stillebroer, Ingrid M.E. Desar, Marye J. Boers‐Sonderen et al. · Journal of Nuclear Medicine · 2014 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

Two-step radio-immunotargeting of renal-cell carcinoma xenografts in nude mice with anti-renal-cell-carcinoma X anti-DTPA bispecific monoclonal antibodies

M. H. G. C. Kranenborg, Otto C. Boerman, Jeannette Oosterwijk‐Wakka et al. · International Journal of Cancer · 1998 · 27 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC

Jeannette Oosterwijk‐Wakka, Mirjam C.A. de Weijert, Gerben M. Franssen et al. · Neoplasia · 2015 · 17 citations · Full text

Medicine, Oncology, Pharmacology +16

Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia

Tom J.H. Arends, J. Falke, Rianne J.M. Lammers et al. · World Journal of Urology · 2014 · 14 citations

Medicine, Pharmacology, Urology +8